Jacob Chacko, Director at 4D Molecular Therapeutics, Inc. (FDMT), sold 5,000 shares at $20.05 ($100K) on 2023-04-21, disclosed to the SEC on 2023-04-25.
Scheduled sale ($100k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |